Janney Montgomery Scott
SMMT icon

Janney Montgomery Scott’s Summit Therapeutics SMMT Stock Holding History

Janney Montgomery Scott’s Portfolio SMMT Stock Details SMMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$370K Buy
21,887
+9,325
+74% +$139K ﹤0.01% 2605
2026
Q2 		$183K Buy
+12,562
New +$223K ﹤0.01% 3007
2025
Q2 		– Sell
-17,610
Closed -$340K – 2818
2025
Q1 		$340K Buy
17,610
+1,894
+12% +$38K ﹤0.01% 2232
2024
Q4 		$280K Buy
15,716
+4,443
+39% +$86.1K ﹤0.01% 2352
2024
Q3 		$247K Buy
+11,273
New +$158K ﹤0.01% 2407

Other funds holding SMMT

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $72.4B AUM 31.32% 1-Year Est. Return
Candriam SCA
Candriam SCA Strassen, Luxembourg, Luxembourg $22.5B AUM 50.38% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return

Janney Montgomery Scott's SMMT Position: Q3 2026 in Review

Janney Montgomery Scott increased its Summit Therapeutics (SMMT) stake by 74% in Q3 2026, buying an estimated $139K and bringing the position to 21,887 shares worth $370K. The position accounts for ﹤0.01% of the portfolio, ranked #2605.

Janney Montgomery Scott first reported a position in SMMT in Q3 2024 and has held it in 5 quarters since. 211 funds tracked by Wall St. Rank hold SMMT as of Q3 2026.

  • Janney Montgomery Scott held 21,887 shares of Summit Therapeutics worth $370K as of Q3 2026.
  • Janney Montgomery Scott bought 9,325 Summit Therapeutics shares in Q3 2026, an estimated $139K.
  • Summit Therapeutics made up ﹤0.01% of Janney Montgomery Scott's portfolio in Q3 2026, its #2605 holding.
  • Janney Montgomery Scott first reported a position in Summit Therapeutics in Q3 2024 and has held it in 5 quarters since.
  • 211 funds tracked by Wall St. Rank held Summit Therapeutics as of Q3 2026.

Based on Janney Montgomery Scott's 13F filing for Q3 2026, filed 12 Nov 2026.